The US Food and Drug and Administration has released the authorization of a medicine known as Farxiga ( dapaglifozin ) to assist deal with men and women with type 2 diabetes. The pills , used in combination with dieting and exercise, are proven to enhance control over blood sugar.

Type 2 diabetes is identified by higher bloodstream glucose ( hyperglycemia ). This really is a direct result the human body becoming not able to generate as much as necessary insulin, or otherwise having the ability to utilize the insulin correctly ( insulin resistance ).

Farxiga, a sodium-glucose co-transporter 2 inhibitor ( SGLT2 ), functions by stopping the kidney from reabsorbing glucose. This raises the excretion of glucose and also decreases glucose levels.

The most familiar negative effects from Farxiga in laboratory tests were fungal bacterial infections and also urinary system bacterial infections.